Cuprina Holdings [Cayman] Limited (CUPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CUPR | CMMB | ALZN | ||
| Company | Cuprina Holdings [Cayman] Limited | Chemomab Therapeutics Ltd ADR | Alzamend Neuro Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.4150 | 1.5800 | 1.9900 | ||
| High | 0.4151 | 1.5800 | 2.0600 | ||
| Low | 0.3862 | 1.4600 | 1.9500 | ||
| Latest | 0.4150 | 1.5000 | 2.0300 | ||
| Change | -0.0002 | -0.0700 | +0.0600 | ||
| % Change | -0.05% | -4.46% | +3.05% | ||
| Volume | 155,061 | 32,216 | 38,041 | ||
| 20-Day Average Volume | 91,938 | 95,226 | 81,197 | ||
| Previous Close | 0.4152 | 1.5700 | 1.9700 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.4355 | 1.5810 | 1.9650 | ||
| 20-Day Raw Stochastic | 20.03% | 23.42% | 66.18% | ||
| 20-Day Relative Strength | 40.85 | 41.09 | 49.67 | ||
| Weighted Alpha | -73.18 | -77.10 | -63.31 | ||
| Today's Opinion | 100% Sell | 100% Sell | 88% Sell | ||
| Previous Opinion | 100% Sell | 100% Sell | 100% Sell | ||
| Last Month's Opinion | 72% Sell | 100% Sell | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.49% since 02/13/26 | -0.66% since 02/13/26 | +24.54% since 02/13/26 | ||
| Low | 0.3862 on 02/23/26 | 1.4000 on 02/18/26 | 1.5800 on 02/17/26 | ||
| High | 0.4490 on 02/17/26 | 1.6400 on 02/19/26 | 2.0600 on 02/23/26 | ||
| 1-Month | |||||
| %Chg | -1.12% since 01/23/26 | -10.71% since 01/23/26 | -7.73% since 01/23/26 | ||
| Low | 0.3862 on 02/23/26 | 1.4000 on 02/18/26 | 1.5800 on 02/17/26 | ||
| High | 0.5300 on 01/29/26 | 1.8270 on 01/26/26 | 2.2600 on 01/26/26 | ||
| 3-Month | |||||
| %Chg | -41.55% since 11/21/25 | -40.71% since 11/21/25 | +3.57% since 11/21/25 | ||
| Low | 0.3760 on 12/31/25 | 1.4000 on 02/18/26 | 1.5800 on 02/17/26 | ||
| High | 0.7098 on 11/24/25 | 2.7700 on 12/08/25 | 2.5350 on 01/22/26 | ||
| 6-Month | |||||
| %Chg | -58.91% since 08/22/25 | -57.87% since 08/22/25 | -18.47% since 08/22/25 | ||
| Low | 0.3760 on 12/31/25 | 1.4000 on 02/18/26 | 1.5800 on 02/17/26 | ||
| High | 2.4500 on 09/10/25 | 3.8550 on 08/26/25 | 2.6800 on 10/31/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,719 | 9,663 | 7,489 | ||
| Shares Outstanding, K | 21,000 | 6,155 | 3,802 | ||
| Annual Sales | 40,000 | 0 | 0 | ||
| Annual Net Income | -1,150,000 | -13,950,000 | -4,510,000 | ||
| Last Quarter Sales | N/A | 0 | 0 | ||
| Last Quarter Net Income | N/A | -1,740,000 | -1,000,000 | ||
| 60-Month Beta | N/A | 0.56 | -0.24 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -0.36 on 08/14/25 | -0.30 on 12/09/25 | ||
| Latest Earnings Date | 05/13/26 | 03/02/26 | 03/09/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||